NCT06943794Not yet recruiting
Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial
Gastric Cancer Prevention Strategies Based on Eradication of Helicobacter Pylori Subtypes at High Risk for Gastric Cancer: a Practical Cluster-randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 25 Feb 2026
Brief summary (registry, in English)
This study is a prospective, multicenter cluster randomized controlled trial. Additional fecal screening for high-risk SNP subtypes, in conjunction with routine Hp testing, may improve the identification of individuals at high risk for gastric cancer. Moreover, the implementation of eradication interventions in high-risk groups has the potential to significantly reduce the incidence and progression of gastric cancer.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 4824 (estimated)
- First submitted
- 20 Mar 2025
- Start date
- 30 Mar 2026
- Primary completion date
- 1 May 2030
- Lead sponsor
- Fudan University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06943794
What you commit to
- Study type: Interventional
- Planned participants: 4824
- From 30 Mar 2026 to the primary completion date, 1 May 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- A history of diagnosed gastric cancer or other malignant tumors of the digestive tract.
- Comorbid severe underlying conditions (e.g., severe cardiopulmonary insufficiency, liver or renal failure, etc.) that are likely to result in a short life expectancy or render long-term follow-up impractical.
- Severe mental illness or incapacity to participate in the study due to lack of civil behavior.
- Other conditions that the investigator deems inappropriate for participation in the study.
Other
- Pregnant or breastfeeding women.
Who the study is looking for
- Age ≥ 40 years, gender is not limited.
- Voluntary participation with signed informed consent.
- No H. pylori eradication treatment received within the past 1 month.
- Able to complete stool sample collection and related examinations as per study requirements.
- Detected as high-risk by Hp subtype test.
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| People's Hospital of Tongling City Coordinator of this site? Confirm its status | Tongling | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.